Curarisation and Intubation Conditions During Videolaryngoscopy With Glidescope Titanium

Tracheal Intubation Clinical Trial

— GICAC  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02404142
• Other study ID #: PI14034
• Status: Completed
• Phase: Phase 4
• First received: March 17, 2015
• Last updated: January 8, 2018
• Start date: February 20, 2015
• Est. completion date: August 5, 2016

Study information

• Verified date: January 2018
• Source: CHU de Reims
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this prospective, randomized study, the investigators assess the intubation conditions during videolaryngoscopy with Glidescope Titanium whether patients receive (curare (Atracurium) group) or no (control group) within elective surgery patients with no difficult intubation prediction

Description:

In this prospective, randomized study, the investigators assess the intubation conditions during videolaryngoscopy with Glidescope Titanium whether patients receive (curare (Atracurium)group) or no (control group) within elective surgery patients with no difficult intubation prediction. The IDS score assessed by an anesthesiologist from the video-recording is the primary outcome. All general anesthesias are standardized using Target Control Infusion of propofol and sufentanil. The investigators also compare IDS scores as assessed by intubators, time for tracheal intubation, and laryngeal morbidity in both groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: August 5, 2016
• Est. primary completion date: April 5, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Elective Surgery Adult Patients

• no difficult intubation prediction

Exclusion Criteria:

Related Conditions & MeSH terms

• Tracheal Intubation

Intervention

Drug:
• Curare (Atracurium)
Curare (Atracurium) versus saline isotonic solution for tracheal intubation
• saline isotonic solution

Locations

Country	Name	City	State
France	Chu de Reims	Reims

Sponsors (2)

Lead Sponsor	Collaborator
CHU de Reims	Verathon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IDS score video-assessed as described by Adnet et al. Measurement will be made by 2 experts anesthesiologists for centralized reading	Number of IDS scores <2 are compared	Assessment will be done at the end of the inclusions period (9 months)
Secondary	IDS score assesed by the intubator anesthesiologist		3 days post intubation